299 related articles for article (PubMed ID: 12935820)
21. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression.
Legendre F; Dudhia J; Pujol JP; Bogdanowicz P
J Biol Chem; 2003 Jan; 278(5):2903-12. PubMed ID: 12419823
[TBL] [Abstract][Full Text] [Related]
22. Dexamethasone enhances SOX9 expression in chondrocytes.
Sekiya I; Koopman P; Tsuji K; Mertin S; Harley V; Yamada Y; Shinomiya K; Nifuji A; Noda M
J Endocrinol; 2001 Jun; 169(3):573-9. PubMed ID: 11375127
[TBL] [Abstract][Full Text] [Related]
23. WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes.
Sen M; Cheng YH; Goldring MB; Lotz MK; Carson DA
Arthritis Rheum; 2004 Feb; 50(2):488-97. PubMed ID: 14872491
[TBL] [Abstract][Full Text] [Related]
24. Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9.
Li Y; Tew SR; Russell AM; Gonzalez KR; Hardingham TE; Hawkins RE
Tissue Eng; 2004; 10(3-4):575-84. PubMed ID: 15165474
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy.
Tchetina EV; Di Battista JA; Zukor DJ; Antoniou J; Poole AR
Arthritis Res Ther; 2007; 9(4):R75. PubMed ID: 17683641
[TBL] [Abstract][Full Text] [Related]
26. Intrajoint comparisons of gene expression patterns in human osteoarthritis suggest a change in chondrocyte phenotype.
Yagi R; McBurney D; Laverty D; Weiner S; Horton WE
J Orthop Res; 2005 Sep; 23(5):1128-38. PubMed ID: 15936918
[TBL] [Abstract][Full Text] [Related]
27. Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed in healthy and osteoarthritic human articular chondrocytes and stimulate matrix synthesis.
Bobacz K; Gruber R; Soleiman A; Graninger WB; Luyten FP; Erlacher L
Osteoarthritis Cartilage; 2002 May; 10(5):394-401. PubMed ID: 12027540
[TBL] [Abstract][Full Text] [Related]
28. Bone morphogenetic protein-mediating receptor-associated Smads as well as common Smad are expressed in human articular chondrocytes but not up-regulated or down-regulated in osteoarthritic cartilage.
Bau B; Haag J; Schmid E; Kaiser M; Gebhard PM; Aigner T
J Bone Miner Res; 2002 Dec; 17(12):2141-50. PubMed ID: 12469908
[TBL] [Abstract][Full Text] [Related]
29. Anabolic actions of IGF-I and TGF-beta1 on Interleukin-1beta-treated human articular chondrocytes: evaluation in two and three dimensional cultures.
Seifarth C; Csaki C; Shakibaei M
Histol Histopathol; 2009 Oct; 24(10):1245-62. PubMed ID: 19688693
[TBL] [Abstract][Full Text] [Related]
30. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer.
Bridgewater LC; Lefebvre V; de Crombrugghe B
J Biol Chem; 1998 Jun; 273(24):14998-5006. PubMed ID: 9614107
[TBL] [Abstract][Full Text] [Related]
31. Regulation of anabolic and catabolic gene expression in normal and osteoarthritic adult human articular chondrocytes by osteogenic protein-1.
Fan Z; Chubinskaya S; Rueger DC; Bau B; Haag J; Aigner T
Clin Exp Rheumatol; 2004; 22(1):103-6. PubMed ID: 15005012
[TBL] [Abstract][Full Text] [Related]
32. Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes.
Sanchez C; Deberg MA; Piccardi N; Msika P; Reginster JY; Henrotin YE
Osteoarthritis Cartilage; 2005 Nov; 13(11):988-97. PubMed ID: 16168681
[TBL] [Abstract][Full Text] [Related]
33. Hyperosmolarity regulates SOX9 mRNA posttranscriptionally in human articular chondrocytes.
Tew SR; Peffers MJ; McKay TR; Lowe ET; Khan WS; Hardingham TE; Clegg PD
Am J Physiol Cell Physiol; 2009 Oct; 297(4):C898-906. PubMed ID: 19657054
[TBL] [Abstract][Full Text] [Related]
34. Expansion of human articular chondrocytes and formation of tissue-engineered cartilage: a step towards exploring a potential use of matrix-induced cell therapy.
Munirah S; Samsudin OC; Aminuddin BS; Ruszymah BH
Tissue Cell; 2010 Oct; 42(5):282-92. PubMed ID: 20810142
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9.
Tsuda M; Takahashi S; Takahashi Y; Asahara H
J Biol Chem; 2003 Jul; 278(29):27224-9. PubMed ID: 12732631
[TBL] [Abstract][Full Text] [Related]
36. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.
Lefebvre V; Huang W; Harley VR; Goodfellow PN; de Crombrugghe B
Mol Cell Biol; 1997 Apr; 17(4):2336-46. PubMed ID: 9121483
[TBL] [Abstract][Full Text] [Related]
37. Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors.
Stokes DG; Liu G; Dharmavaram R; Hawkins D; Piera-Velazquez S; Jimenez SA
Biochem J; 2001 Dec; 360(Pt 2):461-70. PubMed ID: 11716775
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling.
Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J
Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284
[TBL] [Abstract][Full Text] [Related]
39. The Effects of Age and Cell Isolation on Collagen II Synthesis by Articular Chondrocytes: Evidence for Transcriptional and Posttranscriptional Regulation.
Asopa V; Vincent T; Saklatvala J
Biomed Res Int; 2020; 2020():4060135. PubMed ID: 32461985
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter.
Porée B; Kypriotou M; Chadjichristos C; Beauchef G; Renard E; Legendre F; Melin M; Gueret S; Hartmann DJ; Malléin-Gerin F; Pujol JP; Boumediene K; Galéra P
J Biol Chem; 2008 Feb; 283(8):4850-65. PubMed ID: 18065760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
